Nearly two in 10 normal-weight Korean women perceive themselves as obese, according to a recent survey. The findings are raising concerns over the use of increasingly popular injectable weight-loss drugs among people who are not obese. According to a survey by the Korean Society for the Study of Obesity (KSSO), Monday, 18.9 percent of normal-weight women aged 20 or older perceived themselves as obese. The findings were based on data from adults who participated in the Korea Disease Control and Prevention Agency's Korea National Health and Nutrition Examination Survey between 2022 and 2024. The figure was more than four times higher than among normal-weight men, only 4.1 percent of whom perceived themselves as obese. Under the KSSO’s obesity treatment guidelines, body mass index (BMI) — calculated by dividing weight by height squared — is classified into five categories: A BMI of 18.5 to 22.9 is considered normal weight, 23 to 24.9 pre-obesity, 25 to 29.9 stage 1 obesity, 30 to 34.9 stage 2 obesity and 25 or higher is categorized as stage 3 obesity. Among women classified as pre-obe